Latest updates for Glenmark Holding
Fresh curated links around Glenmark Holding are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Glenmark launches generic Olanzapine injection in US
- Glenmark Shifts to High-Margin Proprietary Space with Historic European Launch of Winlevi Acne Cream
- Glenmark Pharma Share: How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Glenmark Shifts to High-Margin Proprietary Space with Historic European Launch of Winlevi Acne Cream
Synopsis: Glenmark Pharmaceuticals has launched Winlevi® (clascoterone 10 mg/g cream) across key European markets for the treatment of acne vulgaris. The launch marks Glenmark’s fi...
Glenmark Pharma Share: How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?
Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs 19,000 crore AbbVie deal that could unl...
Marksans Pharma acquires German OTC distributor ABCnow GmbH for €892,384
The acquisition gives Marksans direct front-end sales and distribution infrastructure in Germany, which will be used for marketing products manufactured across its India, UK, and U...
<![CDATA[GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc. ]]>
<![CDATA[Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion]]>
Merck launches GCC in Bengaluru
Merck’s Bengaluru GCC to bring together approximately 3,300 professionals
<![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]>
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations
Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply TAIPEI, TAIWAN – Media Out...
Dept. of Justice: Wisconsin DOJ announces $29.6 million settlement with Glenmark over alleged conspiracy to inflate pric...
MADISON, Wis. – The Wisconsin Department of Justice (DOJ) joined a coalition of 48 states and territories announcing a $29.6 million settlement with Glenmark to resolve allegations...
Gland Pharma: What should you do?
Margin improvement from higher value-added products and expanding portfolio should support earnings growth
GVRP, StepsBio set up CoE for formulations R&D in Bengaluru
GSRC is designed to tackle complex formulation challenges by combining advanced scientific infrastructure with specialised workflows for drug delivery systems, sterile injectables,...
Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal
<![CDATA[Biogen Enters $1 Billion Agreement to Acquire RayThera Inc. ]]>
Garware Fulflex Completes Acquisition of 300,000-Square-Foot Fully Automated Medical Products Manufacturing Facility in...
Garware Fulflex Completes Acquisition of 300,000-Square-Foot Fully Automated Medical Products Manufacturing Facility in The United States
Granules India gets First-To-File status for generic Lumryz tablets in US
This was Granules’ second Sole First-to-File ANDA, following its earlier approval for Amphetamine Extended-Release Tablets,
<![CDATA[Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Joh...
Blenrep
Blenrep Anonymous (not verified) Thu, 05/28/2026 - 11:40 field_thread_url https://cafepharma.com/boards/threads/blenrep.714532/ board na...
Novartis: 'Hold' On Continued Generic Erosion And Need For H2 2026 Catalysts
<![CDATA[AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal]]>
Blenrep
Blenrep Anonymous (not verified) Thu, 06/18/2026 - 23:58 field_thread_url https://cafepharma.com/boards/threads/blenrep.714532/ board na...
AbbVie to Acquire Apogee Therapeutics for $10.9B
Apogee’s lead candidate zumilokibart, an IL-13 inhibitor also called APG777, is a long-acting treatment that, according to the company, holds “pipeline-in-a-product potential” beca...
Flemming’s replacement
Flemming’s replacement Anonymous (not verified) Wed, 06/03/2026 - 14:44 field_thread_url https://cafepharma.com/boards/threads/flemming%E2%80%99s-replaceme...
Shilpa Medicare Subsidiary Acquires 30.4% Stake Worth ₹63 Cr in Spanish Biotech Firm Gate2Brain
Synopsis: Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, will acquire a 30.4% stake in Spanish biotech company Gate2Brain for €7 million (around Rs. 63 crore). The p...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.